http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57130971-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f2aa9565f6a60fddb5b4a47449ed278
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-43
filingDate 1981-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de1d83d1bd9dedb580b505f58641f73f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ea55e3cecbfe54ef2da6e48980ef7f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9385cb1bc9e4593ec24330f6c5906d45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d646d65864ba2a1bbb9d42467d7351ef
publicationDate 1982-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57130971-A
titleOfInvention Preparation of 4-(3-amino-2-hydroxy-propoxy)indole
abstract PURPOSE: To prepare the titled substance by hydrolyzing 4-(2-hydroxy-3-phthalimino-propoxy)indole obtained by the reaction of 4-hydroxyindole with the reaction produce of epichlorohydrin and phthalimide. n CONSTITUTION: The compound of formula III is prepared by (1) reacting epichlorohydrin with phthalimide in a solvent such as water, alcohol, etc. at 40W 100°C pref. in the presence of a basic catalyst such as tri-(n-butyl)amine, etc. to obtain a mixture of the compound of formulaIand formula II, (2) reacting the mixture, without separating into each component, with 4-hydroxyindole in a solvent such as toluene in the presence of an alkali (e.g. potassium carbonate) at 80W160°C, and (3) hydrolyzing the resultant 4-(2-hydroxy-3-phthalimino-propoxy) indole at 90W105°C in the presence of an alkali (e.g. KOH). n USE: Intermediate of pharmaceuticals. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009185047-A
priorityDate 1981-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420236386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88743783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421214051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232996863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13118493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236423964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6809
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474477

Total number of triples: 41.